2018
DOI: 10.1186/s13148-018-0482-3
|View full text |Cite
|
Sign up to set email alerts
|

Competing endogenous RNA expression profiling in pre-eclampsia identifies hsa_circ_0036877 as a potential novel blood biomarker for early pre-eclampsia

Abstract: BackgroundThe etiology and pathogenesis of pre-eclampsia (PE) is unclear, and there is no ideal early clinical biomarker for prediction of PE. The competing endogenous RNA (ceRNA) hypothesis is a new approach to uncover the molecular pathology of PE. The first aim of this study was to perform messenger RNA, long non-coding RNA, and circular RNA (circRNA) expression profiling of human normal and severe pre-eclampsia (SPE) placentas. circRNA, which has a stable structure, is a more suitable biomarker than other … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

3
61
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 87 publications
(64 citation statements)
references
References 45 publications
3
61
0
Order By: Relevance
“…Studies on PE and circRNAs are still in the preliminary stages, but in a recent report, differential circRNA expression profiles were observed in blood and placenta tissues of PE patients [11,25]. Using clinical correlation studies, some differentially expressed circRNAs, such as hsa circ 0036877, circRNA-0004904, and circRNA-0001855, might function as competing endogenous RNAs and serve as novel blood biomarkers for the early prediction of PE [26,27]. In the present study, we evaluated the possible functions of a circRNA, circPAPPA, which we previously characterized.…”
Section: Discussionmentioning
confidence: 99%
“…Studies on PE and circRNAs are still in the preliminary stages, but in a recent report, differential circRNA expression profiles were observed in blood and placenta tissues of PE patients [11,25]. Using clinical correlation studies, some differentially expressed circRNAs, such as hsa circ 0036877, circRNA-0004904, and circRNA-0001855, might function as competing endogenous RNAs and serve as novel blood biomarkers for the early prediction of PE [26,27]. In the present study, we evaluated the possible functions of a circRNA, circPAPPA, which we previously characterized.…”
Section: Discussionmentioning
confidence: 99%
“…They have been found implicated with various cancers, including colorectal, lung, and cervical cancer . Hitherto noticed features of circRNA are mainly based on evidence gathered from human, and studies on other species are insufficient …”
Section: Introductionmentioning
confidence: 99%
“…[18][19][20] Hitherto noticed features of circRNA are mainly based on evidence gathered from human, and studies on other species are insufficient. [21][22][23][24] This study aims to explore the multiple factors that potentially lead to high abortion frequency exist in SCNT fetus generation during late gestation. To this end, we collected two aberrant pregnant placenta (abnormal group, AG) and three normal pregnant placenta (normal group, NG) at late gestation (180-210 days) of bovine SCNT fetus.…”
Section: Introductionmentioning
confidence: 99%
“…8 In addition, circRNAs possess a great potential as disease biomarkers for diagnosis, prognosis and targeted therapy, especially in tumor 9,10 and neurodegeneration. 14,15 Yet, whether specific circRNAs could be biomarkers of fetal growth restriction (FGR) is unknown and requires further analysis and investigation, especially in clinical research. 14,15 Yet, whether specific circRNAs could be biomarkers of fetal growth restriction (FGR) is unknown and requires further analysis and investigation, especially in clinical research.…”
mentioning
confidence: 99%
“…[11][12][13] In obstetrics and gynecology, the relationship between circRNAs and pre-eclampsia (PE) has been explored in several studies. 14,15 Yet, whether specific circRNAs could be biomarkers of fetal growth restriction (FGR) is unknown and requires further analysis and investigation, especially in clinical research.…”
mentioning
confidence: 99%